| Titolo |
Pubblicato in |
Anno |
| Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis |
CANCERS |
2024 |
| PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey |
TUMORI |
2024 |
| An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients |
CURRENT ONCOLOGY REPORTS |
2024 |
| CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line |
JOURNAL OF TRANSLATIONAL MEDICINE |
2024 |
| Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study |
THE ONCOLOGIST |
2024 |
| Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis |
BMC CANCER |
2024 |
| Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments |
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY |
2024 |
| The role of CD73 in predicting the response to immunotherapy in head and neck cancer patients |
PATHOLOGY RESEARCH AND PRACTICE |
2024 |
| The multidisciplinary management of locally advanced rectal cancer |
EXPERT REVIEW OF ANTICANCER THERAPY |
2024 |
| Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis |
BMC CANCER |
2024 |
| Correction to: Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study (npj Breast Cancer, (2024), 10, 1, (58), 10.1038/s41523-024-00657-z) |
NPJ BREAST CANCER |
2024 |
| Assessing risks and knowledge gaps on the impact of systemic therapies in early breast cancer on female fertility: A systematic review of the literature |
CANCER TREATMENT REVIEWS |
2024 |
| Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature |
CANCERS |
2024 |
| Pregnancy-associated breast cancer: a diagnostic and therapeutic challenge |
DIAGNOSTICS |
2023 |
| Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach |
CANCER IMMUNOLOGY, IMMUNOTHERAPY |
2023 |
| Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2023 |
| 86P {KRAS} G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma |
JOURNAL OF THORACIC ONCOLOGY |
2023 |
| Risk of Oral Squamous Cell Carcinoma in One Hundred Patients with Oral Lichen Planus: A Follow-Up Study of Umberto I University Hospital of Rome |
CANCERS |
2023 |
| KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma |
LUNG CANCER |
2023 |
| Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer |
CLINICAL CANCER RESEARCH |
2023 |
